APA ציטוט

Ono, Y., Takada, K., Osoegawa, A., Kinoshita, F., Oba, T., Tsukamoto, S., . . . Mori, M. (2020). First-line osimertinib for leptomeningeal metastasis from lung adenocarcinoma with EGFR mutation as the initial and solitary site of postoperative recurrence. Int Cancer Conf J.

Citação norma Chicago

Ono, Yuki, Kazuki Takada, Atsushi Osoegawa, Fumihiko Kinoshita, Taro Oba, Shuichi Tsukamoto, Tetsuzo Tagawa, Yoshinao Oda, and Masaki Mori. "First-line Osimertinib for Leptomeningeal Metastasis From Lung Adenocarcinoma With EGFR Mutation As the Initial and Solitary Site of Postoperative Recurrence." Int Cancer Conf J 2020.

ציטוט MLA

Ono, Yuki, et al. "First-line Osimertinib for Leptomeningeal Metastasis From Lung Adenocarcinoma With EGFR Mutation As the Initial and Solitary Site of Postoperative Recurrence." Int Cancer Conf J 2020.